Table 2:

Univariate statistics of angiographic results and methods of LIT-MCD for patients with poor clinical outcome and favorable outcome

Clinical Outcome at 90 DaysP
Poor (mRS, 3–6)Favorable (mRS, 0–2)
No. of patients4248
Location of occlusion
    Proximal M1a17 (41%)3 (6%)<.001b
    Distal M112 (29%)17 (35%).488b
    M2c13 (31%)28 (58%).009b
No. of patients with
    Preprocedural TICI of grade 038 (90%)37 (77%).089b
    Poor collaterals (CFGS, grade 1)6 (14%)2 (4%).139d
    Moderate collaterals (grade 2)35 (83%)41 (85%).786b
    Ample collaterals (grade 3)1 (2%)5 (10%).209d
Dose of urokinase (×103 U) (mean)237 ± 9.1265 ± 10.0.172e
Use of low dose of urokinase     (≤240,000 U)37 (88%)33 (69%).028b
Use of mechanical clot disruption37 (88%)25 (52%)<.001b
No recanalization (TICI grade 0 +     1)15 (36%)2 (4%)<.001b
Postprocedural TICI grade
    012 (29%)1 (2%)<.001b
    13 (7%)1 (2%).336d
    2a18 (43%)19 (40%).753b
    2b7 (17%)16 (33%).071b
    32 (5%)11 (23%).015b
Procedure-related complications5 (12%)4 (8%).729d
  • a Indicates occlusion of the horizontal segment (M1) of the MCA at or proximal to the lenticulostriate arteries.

  • b χ2 test.

  • c Insular segment of the MCA.

  • d Fisher exact test.

  • e Unpaired t test.